Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Beta-blockers in Heart Failure Collaborative Group"'
Autor:
Kotecha, D, Gill, SK, Flather, MD, Holmes, J, Packer, M, Rosano, G, Böhm, M, McMurray, JJV, Wikstrand, J, Anker, SD, van Veldhuisen, DJ, Manzano, L, von Lueder, TG, Rigby, AS, Andersson, B, Kjekshus, J, Wedel, H, Ruschitzka, F, Cleland, JGF, Damman, K, Redon, J, Coats, AJS, Beta-Blockers in Heart Failure Collaborative Group
BACKGROUND: Moderate and moderately severe renal impairment are common in patients with heart failure and reduced ejection fraction, but whether beta-blockers are effective is unclear, leading to underuse of life-saving therapy. OBJECTIVES: This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::27c2e978494a6f6fb69c1ac3de3ee792
https://openaccess.sgul.ac.uk/id/eprint/111561/1/1-s2.0-S073510971937932X-main.pdf
https://openaccess.sgul.ac.uk/id/eprint/111561/1/1-s2.0-S073510971937932X-main.pdf
Autor:
Cleland, JGF, Bunting, KV, Flather, MD, Altman, DG, Holmes, J, Coats, AJS, Manzano, L, McMurray, JJV, Ruschitzka, F, van Veldhuisen, DJ, von Lueder, TG, Böhm, M, Andersson, B, Kjekshus, J, Packer, M, Rigby, AS, Rosano, G, Wedel, H, Hjalmarson, Å, Wikstrand, J, Kotecha, D, Beta-blockers in Heart Failure Collaborative Group
Aims: Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40-49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in double-blind, randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d70640350f92470cf6c874180447e549
https://openaccess.sgul.ac.uk/id/eprint/111191/1/148471.pdf
https://openaccess.sgul.ac.uk/id/eprint/111191/1/148471.pdf
Autor:
Kotecha, D, Flather, MD, Altman, DG, Holmes, J, Rosano, G, Wikstrand, J, Packer, M, Coats, AJS, Manzano, L, Böhm, M, van Veldhuisen, DJ, Andersson, B, Wedel, H, von Lueder, TG, Rigby, AS, Hjalmarson, Å, Kjekshus, J, Cleland, JGF, Beta-Blockers in Heart Failure Collaborative Group
BACKGROUND: The relationship between mortality and heart rate remains unclear for patients with heart failure with reduced ejection fraction in either sinus rhythm or atrial fibrillation (AF). OBJECTIVES: This analysis explored the prognostic importa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::fe4dd5e8e63d97cde1157a16594ab2a1
https://openaccess.sgul.ac.uk/id/eprint/112689/1/Heart_rate_heart_rhythm_and_prognostic_benefits.pdf
https://openaccess.sgul.ac.uk/id/eprint/112689/1/Heart_rate_heart_rhythm_and_prognostic_benefits.pdf
Autor:
Kotecha, D, Manzano, L, Krum, H, Rosano, G, Holmes, J, Altman, DG, Collins, PD, Packer, M, Coats, AJS, Cleland, JGF, Kirchhof, P, Von Lueder, TG, Rigby, AS, Andersson, B, Lip, G, Van Veldhuisen, D, Shibata, M, Wedel, H, Böhm, M, Flather, MD, Beta-Blockers in Heart Failure Collaborative Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::32a5086728b996b63e21f520e0beafcc
http://hdl.handle.net/10044/1/31037
http://hdl.handle.net/10044/1/31037
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Karwath, Andreas1,2 (AUTHOR), Bunting, Karina V2,3,4 (AUTHOR), Gill, Simrat K4 (AUTHOR), Tica, Otilia2,4 (AUTHOR), Pendleton, Samantha1 (AUTHOR), Aziz, Furqan1,2 (AUTHOR), Barsky, Andrey D1,2 (AUTHOR), Chernbumroong, Saisakul1 (AUTHOR), Duan, Jinming5 (AUTHOR), Mobley, Alastair R2,3,4 (AUTHOR), Cardoso, Victor Roth1,2,4 (AUTHOR), Slater, Luke1,2 (AUTHOR), Williams, John A1,2 (AUTHOR), Bruce, Emma-Jane2,3,4 (AUTHOR), Wang, Xiaoxia2,3,4 (AUTHOR), Flather, Marcus D6 (AUTHOR), Coats, Andrew J S7 (AUTHOR), Gkoutos, Georgios V1,2,3 (AUTHOR) g.gkoutos@bham.ac.uk, Kotecha, Dipak2,3,4 (AUTHOR) d.kotecha@bham.ac.uk, card AIc group and the Beta-blockers in Heart Failure Collaborative Group (CORPORATE AUTHOR)
Publikováno v:
Lancet. Oct2021, Vol. 398 Issue 10309, p1427-1435. 9p.
Autor:
Beta-Blockers in Heart Failure Collaborative Group, Kotecha, Dipak, Manzano, Luis, Krum, Henry, Rosano, Giuseppe, Holmes, Jane, Altman, Douglas G, Collins, Peter D, Packer, Milton, Wikstrand, John, Coats, Andrew J S, Cleland, John G F, Kirchhof, Paulus, von Lueder, Thomas G, Rigby, Alan S, Andersson, Bert, Lip, Gregory YH, van Veldhuisen, Dirk J, Shibata, Marcelo C, Wedel, Hans, Böhm, Michael, Flather, Marcus D
Publikováno v:
BMJ: British Medical Journal,
Externí odkaz:
https://www.jstor.org/stable/26942320
Autor:
Kotecha, Dipak1,2, Flather, Marcus D.3, Altman, Douglas G.4, Holmes, Jane4, Rosano, Giuseppe5,6, Wikstrand, John7, Packer, Milton8, Coats, Andrew J.S.9,10, Manzano, Luis11, Böhm, Michael12, van Veldhuisen, Dirk J.13, Andersson, Bert14, Wedel, Hans15, von Lueder, Thomas G.2,16, Rigby, Alan S.17, Hjalmarson, Åke14, Kjekshus, John18, Cleland, John G.F.19 john.cleland@glasgow.ac.uk, Beta-Blockers in Heart Failure Collaborative Group (CORPORATE AUTHOR)
Publikováno v:
Journal of the American College of Cardiology (JACC). Jun2017, Vol. 69 Issue 24, p2885-2896. 12p.
Autor:
Cleland, John G F (AUTHOR), Flather, Marcus D (AUTHOR), Altman, Douglas G (AUTHOR), Kotecha, Dipak (AUTHOR), Beta-Blockers in Heart Failure Collaborative Group (CORPORATE AUTHOR)
Publikováno v:
Journal of the American College of Cardiology (JACC). Jan2018, Vol. 71 Issue 1, p105-105. 1p.
Autor:
Kotecha, Dipak (AUTHOR), Altman, Douglas G (AUTHOR), Manzano, Luis (AUTHOR), Flather, Marcus D (AUTHOR), Beta-Blockers in Heart Failure Collaborative Group (CORPORATE AUTHOR)
Publikováno v:
Lancet. 4/25/2015, Vol. 385 Issue 9978, p1618-1619. 2p.